Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:21:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added the MeSH term 'Cutaneous neuroendocrine carcinoma' and updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-28T01:52:02.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:22.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Gastric cancer was added to the list of conditions for the study, broadening the potential population the page pertains to. A new Genetic and Rare Diseases Information Center resource was added under Resources, and the site revision banner updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T13:41:29.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and v3.4.0 removed, indicating a version update that does not change study details or how the page is used.
    Difference
    0.0%
    Check dated 2026-02-05T23:48:35.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4, replacing the previous revision entry.
    Difference
    0.0%
    Check dated 2026-01-15T05:09:37.000Z thumbnail image

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.